AR057153A1 - Metodo in vitro no invasivo para detectar carcinoma transicional de vejiga - Google Patents
Metodo in vitro no invasivo para detectar carcinoma transicional de vejigaInfo
- Publication number
- AR057153A1 AR057153A1 ARP060104455A ARP060104455A AR057153A1 AR 057153 A1 AR057153 A1 AR 057153A1 AR P060104455 A ARP060104455 A AR P060104455A AR P060104455 A ARP060104455 A AR P060104455A AR 057153 A1 AR057153 A1 AR 057153A1
- Authority
- AR
- Argentina
- Prior art keywords
- seq
- detecting
- bladder
- catd
- quantifying
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Un método in vitro no invasivo para detectar la presencia de carcinoma transicional de vejiga en un individuo mediante deteccion y cuantificacion de 1 o más biomarcadores presentes en una muestra de orina, para determinar el estadio o severidad de dicho cáncer o para monitorizar el efecto del tratamiento administrado a un individuo que padece dicho cáncer. Reivindicacion 2: Método segun la reivindicacion 1, caracterizado porque la etapa a) compende detectar y cuantificar uno o más biomarcadores seleccionados entre TTHY (SEQ ID 1), ACY1 (SEQ ID 2), AKR1A1 (SEQ ID 3), ALDOB (SEQ ID 4), ANXA4 (SEQ ID 5), BIEA (SEQ ID 6), BLVRB (SEQ ID 7), CATD (SEQ ID 8), CATD K (SEQ ID 9), CO3 (SEQ ID 10, SEQ ID 11), CPGL (SEQ ID 12), ENOA (SEQ ID 13, SEQ ID 14), FRIL (SEQ ID 15), GDIB (SEQ ID 16), GPX3 (SEQ ID 17), GSHB (SEQ ID 18), GSPT1 (SEQ ID 19), IDHC (SEQ ID 20), LMAN2 (SEQ ID 21), LY6G6E (SEQ ID 22), MASP (SEQ ID 23), NADC (SEQ ID 24), NAPSA (SEQ ID 25), PA2G4 (SEQ ID 26), PARK7 (SEQ ID 27), PCBP1 (SEQ ID 28), PDC6I (SEQ ID 29), PPAL (SEQ ID 30), PRDX2 (SEQ ID 31), PTD012 (SEQ ID 32), QPCT (SEQ ID 33), SBP1 (SEQ ID 34), STIP1 (SEQ ID 35), TALDO (SEQ ID 36), WDR1 (SEQ ID 37), AMY (SEQ ID 38, SEQ ID 39, SEQ ID 40), APOA1 (SEQ ID 41), GSN40 (SEQ ID 42), GSN80 (SEQ ID 43) Y RETBP (SEQ ID 44) o una variante transcripcional o post-traduccional de los mismos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05384037A EP1775590A1 (en) | 2005-10-11 | 2005-10-11 | Non-invasive in vitro method to detect transitional cell carcinoma of the bladder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR057153A1 true AR057153A1 (es) | 2007-11-21 |
Family
ID=35431172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060104455A AR057153A1 (es) | 2005-10-11 | 2006-10-11 | Metodo in vitro no invasivo para detectar carcinoma transicional de vejiga |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20090209431A1 (es) |
| EP (4) | EP1775590A1 (es) |
| JP (1) | JP2009511028A (es) |
| KR (1) | KR20080073707A (es) |
| CN (1) | CN101300491A (es) |
| AR (1) | AR057153A1 (es) |
| AU (1) | AU2006301487A1 (es) |
| BR (1) | BRPI0617256A2 (es) |
| CA (1) | CA2624581A1 (es) |
| EA (1) | EA013927B1 (es) |
| NZ (1) | NZ567440A (es) |
| WO (1) | WO2007042256A1 (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0512401D0 (en) * | 2005-06-17 | 2005-07-27 | Randox Lab Ltd | Method |
| ES2323927B1 (es) * | 2007-03-30 | 2010-05-14 | Laboratorios Salvat, S.A. | Metodo in vitro no invasivo para detectar carcinoma transicional de vejiga. |
| JP4922057B2 (ja) | 2007-05-02 | 2012-04-25 | 国立大学法人山梨大学 | 自己免疫性膵炎及び劇症１型糖尿病の検査方法及び検査試薬 |
| FR2919061B1 (fr) | 2007-07-19 | 2009-10-02 | Biomerieux Sa | Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal. |
| FR2919065B1 (fr) | 2007-07-19 | 2009-10-02 | Biomerieux Sa | Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal |
| FR2919063B1 (fr) | 2007-07-19 | 2009-10-02 | Biomerieux Sa | Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal. |
| FR2919062B1 (fr) * | 2007-07-19 | 2009-10-02 | Biomerieux Sa | Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal. |
| ES2565512T3 (es) | 2007-07-19 | 2016-04-05 | bioMérieux | Procedimiento de ensayo de la proteína de unión a ácidos grasos del hígado, de ACE y de CA19-9 para el diagnóstico in vitro del cáncer colorrectal |
| FR2919060B1 (fr) | 2007-07-19 | 2012-11-30 | Biomerieux Sa | Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal. |
| FR2919064B1 (fr) | 2007-07-19 | 2009-10-02 | Biomerieux Sa | Procede de dosage de l'apolipoproteine all pour le diagnostic in vitro du cancer colorectal |
| DE102008011850A1 (de) * | 2008-02-29 | 2009-09-03 | Michael Grzendowski | Biomarker für die Diagnose von Hirntumor |
| WO2009137832A2 (en) * | 2008-05-09 | 2009-11-12 | Duke University | Autoantibodies in the detection and treatment of cancer |
| FR2933773B1 (fr) | 2008-07-10 | 2013-02-15 | Biomerieux Sa | Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal |
| WO2010080935A1 (en) * | 2009-01-11 | 2010-07-15 | Alper Biotech, Llc | Monoclonal antibodies against pcbp-1 antigens, and uses therefor |
| EP2421900A1 (en) | 2009-04-24 | 2012-02-29 | Alper Biotech, Llc | Monoclonal antibodies against pcbp-1 antigens, and uses therefor |
| TWI390204B (zh) * | 2010-02-11 | 2013-03-21 | Univ Chang Gung | Biomarker of bladder cancer and its detection method |
| KR20130048240A (ko) | 2010-07-14 | 2013-05-09 | 알퍼 바이오테크, 엘엘씨 | Ｐｃｂｐ―１ 항원에 대한 모노클로날 항체, 및 그의 용도 |
| WO2013040758A1 (zh) * | 2011-09-20 | 2013-03-28 | 深圳华大基因科技有限公司 | 膀胱移行细胞癌易感性的相关基因及其预测方法和系统 |
| RU2505818C2 (ru) * | 2012-01-10 | 2014-01-27 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт онкологии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИ онкологии" СО РАМН) | Способ прогнозирования исходов химиолучевой терапии плоскоклеточных карцином головы и шеи |
| WO2015069187A1 (en) * | 2013-11-05 | 2015-05-14 | Agency For Science, Technology And Research | Bladder Carcinoma Biomarkers |
| CN106605147B (zh) * | 2014-08-26 | 2019-06-18 | 学校法人庆应义塾 | 抗癌剂的感受性的判定标记 |
| WO2016198835A1 (en) | 2015-06-08 | 2016-12-15 | Arquer Diagnostics Limited | Methods and kits |
| US11519916B2 (en) | 2015-06-08 | 2022-12-06 | Arquer Diagnostics Limited | Methods for analysing a urine sample |
| JP6325177B2 (ja) * | 2015-10-14 | 2018-05-16 | 公立大学法人横浜市立大学 | 腎癌薬物療法の効果判定のための血中バイオマーカー |
| CN106093397A (zh) * | 2016-06-13 | 2016-11-09 | 厦门大学 | 以谷胱甘肽过氧化物酶 3为标志物的乳腺癌诊断试剂盒 |
| KR101782768B1 (ko) * | 2016-08-26 | 2017-09-28 | 주식회사 피시피아비아이티 | 신장질환 조기 진단용 바이오마커 sbp1 및 이의 이용 |
| US20200048662A1 (en) * | 2016-10-11 | 2020-02-13 | Braskem S.A. | Microorganisms and methods for the co-production of ethylene glycol and isobutene |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6221621B1 (en) * | 1997-03-06 | 2001-04-24 | Bard Diagnostic Sciences, Inc. | Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated |
| US20020172987A1 (en) * | 1998-02-12 | 2002-11-21 | Terstappen Leon W.M.M. | Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
| AU3316600A (en) * | 1999-02-22 | 2000-09-21 | Torben F. Orntoft | Gene expression in bladder tumors |
| WO2001032920A2 (en) * | 1999-11-03 | 2001-05-10 | Metris Therapeutics Limited | Agents implicated in endometriosis |
| CA2402772A1 (en) * | 2000-03-13 | 2001-09-20 | Amgen Inc. | Apolipoprotein-a-i regulation of t-cell signalling |
| AU2001266759A1 (en) * | 2000-06-07 | 2001-12-17 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the acp2 gene |
| US20040076955A1 (en) * | 2001-07-03 | 2004-04-22 | Eos Biotechnology, Inc. | Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| DE10238046A1 (de) * | 2002-08-20 | 2004-03-04 | Giesing, Michael, Prof. Dr.med. | Verfahren zum Untersuchen von Körperflüssigkeiten auf Krebszellen, dessen Verwendung, entsprechende Analysekits und Verwendung bestimmter Wirkstoffe zur Behandlung von Krebs |
| AU2003294828A1 (en) * | 2002-12-17 | 2004-07-09 | Sinogenomax Co. Ltd. Chinese National Human Genomecenter | Specific markers for pancreatic cancer |
| WO2004079368A2 (en) * | 2003-03-08 | 2004-09-16 | Auvation Ltd | Markers for colorectal cancer |
| EP1784499A4 (en) * | 2004-07-23 | 2007-08-22 | Eastern Virginia Med School | BIOMARKER FOR BUBBLE CANCER |
| BRPI0419002A (pt) * | 2004-08-13 | 2007-12-11 | Indivumed Gmbh | método para detectar e para diferenciação entre adenoma colorretal e/ou carcinoma colorretal, método para monitoramento do curso de adenoma colorretal, uso de transtirretina como biomarcador, sistema de teste, arranjo compreendendo moléculas de detecção |
-
2005
- 2005-10-11 EP EP05384037A patent/EP1775590A1/en not_active Withdrawn
-
2006
- 2006-10-10 NZ NZ567440A patent/NZ567440A/en not_active IP Right Cessation
- 2006-10-10 WO PCT/EP2006/009768 patent/WO2007042256A1/en active Application Filing
- 2006-10-10 BR BRPI0617256-3A patent/BRPI0617256A2/pt not_active IP Right Cessation
- 2006-10-10 JP JP2008534919A patent/JP2009511028A/ja active Pending
- 2006-10-10 EA EA200801046A patent/EA013927B1/ru not_active IP Right Cessation
- 2006-10-10 KR KR1020087011307A patent/KR20080073707A/ko not_active Application Discontinuation
- 2006-10-10 CA CA002624581A patent/CA2624581A1/en not_active Abandoned
- 2006-10-10 US US12/083,446 patent/US20090209431A1/en not_active Abandoned
- 2006-10-10 AU AU2006301487A patent/AU2006301487A1/en not_active Abandoned
- 2006-10-10 CN CNA2006800412768A patent/CN101300491A/zh active Pending
- 2006-10-10 EP EP06792410A patent/EP1934616A1/en not_active Ceased
- 2006-10-10 EP EP11164154A patent/EP2367007A3/en not_active Withdrawn
- 2006-10-10 EP EP11164150A patent/EP2369349A3/en not_active Withdrawn
- 2006-10-11 AR ARP060104455A patent/AR057153A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2369349A2 (en) | 2011-09-28 |
| EP2367007A2 (en) | 2011-09-21 |
| JP2009511028A (ja) | 2009-03-19 |
| AU2006301487A1 (en) | 2007-04-19 |
| EP2367007A3 (en) | 2012-04-18 |
| KR20080073707A (ko) | 2008-08-11 |
| NZ567440A (en) | 2011-12-22 |
| US20090209431A1 (en) | 2009-08-20 |
| EA200801046A1 (ru) | 2008-10-30 |
| EP2369349A3 (en) | 2012-04-18 |
| WO2007042256A1 (en) | 2007-04-19 |
| EP1934616A1 (en) | 2008-06-25 |
| EP1775590A1 (en) | 2007-04-18 |
| BRPI0617256A2 (pt) | 2011-07-19 |
| CA2624581A1 (en) | 2007-04-19 |
| EA013927B1 (ru) | 2010-08-30 |
| CN101300491A (zh) | 2008-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR057153A1 (es) | Metodo in vitro no invasivo para detectar carcinoma transicional de vejiga | |
| MX2021009682A (es) | Biomarcadores de cinasa 2 dependientes de ciclinas y sus usos. | |
| ES2572377T3 (es) | Método para la detección de la presencia, o el riesgo, de cáncer de vejiga | |
| ES2570632T3 (es) | Procedimiento de determinación del inhibidor de elastasa de leucocito in vitro del cáncer colorrectal | |
| MX2018012580A (es) | Métodos y kits para el diagnóstico y la estratificación de riesgo en pacientes con isquemia. | |
| NI201100064A (es) | Anticuerpos humanos de la alta afinidad para el receptor il-4 humano fundamento. | |
| ATE511635T1 (de) | System zur optischen kohärenztomographie | |
| ES2572372T3 (es) | Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1 | |
| GT200600407A (es) | Compuestos ppar activos | |
| ATE490465T1 (de) | Diagnose- und prognoseverfahren von blasenkrebs. | |
| JP2006528004A5 (es) | ||
| ATE493290T1 (de) | Alcotestgerät | |
| ATE524774T1 (de) | Beleuchtetes tastenfeld | |
| SG165370A1 (en) | Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites | |
| BR112015015530A2 (pt) | aparelho e dispositivo de exibição | |
| ATE539344T1 (de) | Fluoreszenzmessgerät | |
| BR112012025517A2 (pt) | ____________________________________________________________ anticorpo que reconhece fator inibidor de leucemia (lif) humano e uso de anti-lif anticorpos no tratamento de doenças associadas a proliferação celular não desejada | |
| ES2528321T3 (es) | Detección de a-fucosilación en anticuerpos | |
| EA201500080A1 (ru) | Способ in vitro диагностирования и мониторинга рака | |
| ES2601028T3 (es) | Método de medición inmunológica para el precursor del péptido liberador de gastrina | |
| BR112017006315A2 (pt) | agente terapêutico, uso de um agente terapêutico, métodos in vitro para determinar se um sujeito com melanoma tem um risco maior de desenvolver metástase, de determinação de um regime de tratamento para um sujeito que sofre de melanoma, de tratamento de um sujeito que sofre de melanoma, ensaio in vitro para predizer o risco aumentado de metástase e kits | |
| BR112019001384A2 (pt) | teste de combinação para câncer colorretal | |
| PE20120592A1 (es) | Metodo con biomarcadores para el seguimiento de un tratamiento | |
| UY38393A (es) | Anticuerpos contra bcma soluble | |
| ATE546736T1 (de) | Neues prognoseverfahren in zusammenhang mit postpartaler hämorrhagie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |